Jakob Loven's Insider Trades & SAST Disclosures
Jakob Loven's most recent trade in Kronos Bio Inc was a trade of 25,292 Common Stock done at an average price of $20.8 . Disclosure was reported to the exchange on April 16, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jakob Loven.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kronos Bio Inc | Jakob Loven | Director | Sale of securities on an exchange or to another person at price $ 20.84 per share. | 16 Apr 2021 | 25,292 | 1,344,962 | - | 20.8 | 527,085 | Common Stock |
| Kronos Bio Inc | Jakob Loven | Director | Sale of securities on an exchange or to another person at price $ 20.10 per share. | 16 Apr 2021 | 21,532 | 1,301,556 | - | 20.1 | 432,793 | Common Stock |
| Kronos Bio Inc | Jakob Loven | Director | Sale of securities on an exchange or to another person at price $ 20.25 per share. | 16 Apr 2021 | 9,847 | 1,327,245 | - | 20.3 | 199,402 | Common Stock |
| Kronos Bio Inc | Jakob Loven | Director | Sale of securities on an exchange or to another person at price $ 21.56 per share. | 16 Apr 2021 | 7,870 | 1,337,092 | - | 21.6 | 169,677 | Common Stock |
| Kronos Bio Inc | Jakob Loven | Director | Sale of securities on an exchange or to another person at price $ 21.38 per share. | 16 Apr 2021 | 4,157 | 1,323,088 | - | 21.4 | 88,877 | Common Stock |
| Kronos Bio Inc | Jakob Loven | Director | Sale of securities on an exchange or to another person at price $ 20.63 per share. | 16 Apr 2021 | 19 | 1,301,537 | - | 20.6 | 392 | Common Stock |
| Kronos Bio Inc | Jakob Loven | Director | Sale of securities on an exchange or to another person at price $ 21.78 per share. | 13 Apr 2021 | 24,818 | 1,370,254 | - | 21.8 | 540,536 | Common Stock |
| Kronos Bio Inc | Jakob Loven | Director | Sale of securities on an exchange or to another person at price $ 23.10 per share. | 13 Apr 2021 | 18,938 | 1,395,072 | - | 23.1 | 437,468 | Common Stock |
| Kronos Bio Inc | Jakob Loven | Director | Sale of securities on an exchange or to another person at price $ 22.38 per share. | 13 Apr 2021 | 13,698 | 1,414,010 | - | 22.4 | 306,561 | Common Stock |
| Kronos Bio Inc | Jakob Loven | Director | Sale of securities on an exchange or to another person at price $ 23.35 per share. | 13 Apr 2021 | 9,997 | 1,434,731 | - | 23.4 | 233,430 | Common Stock |
| Kronos Bio Inc | Jakob Loven | Director | Sale of securities on an exchange or to another person at price $ 24.40 per share. | 13 Apr 2021 | 5,738 | 1,428,993 | - | 24.4 | 140,007 | Common Stock |
| Kronos Bio Inc | Jakob Loven | Director | Sale of securities on an exchange or to another person at price $ 25.18 per share. | 13 Apr 2021 | 1,285 | 1,427,708 | - | 25.2 | 32,356 | Common Stock |
| Kronos Bio Inc | Jakob Loven | Director | Sale of securities on an exchange or to another person at price $ 27.09 per share. | 08 Apr 2021 | 38,312 | 1,507,032 | - | 27.1 | 1,037,872 | Common Stock |
| Kronos Bio Inc | Jakob Loven | Director | Sale of securities on an exchange or to another person at price $ 27.91 per share. | 08 Apr 2021 | 24,816 | 1,482,216 | - | 27.9 | 692,615 | Common Stock |
| Kronos Bio Inc | Jakob Loven | Director | Sale of securities on an exchange or to another person at price $ 27.20 per share. | 08 Apr 2021 | 21,660 | 1,460,556 | - | 27.2 | 589,152 | Common Stock |
| Kronos Bio Inc | Jakob Loven | Director | Sale of securities on an exchange or to another person at price $ 26.27 per share. | 08 Apr 2021 | 15,728 | 1,444,828 | - | 26.3 | 413,175 | Common Stock |
| Kronos Bio Inc | Jakob Loven | Director | Sale of securities on an exchange or to another person at price $ 27.21 per share. | 08 Apr 2021 | 100 | 1,444,728 | - | 27.2 | 2,721 | Common Stock |
| Kronos Bio Inc | Jakob Loven | Director | 14 Oct 2020 | 1,376,313 | 1,376,313 | - | - | Common Stock | ||
| Kronos Bio Inc | Jakob Loven | Director | 14 Oct 2020 | 1,304,563 | 0 | - | - | Series A Preferred Stock | ||
| Kronos Bio Inc | Jakob Loven | Director | 14 Oct 2020 | 169,031 | 1,545,344 | - | 16.2 | 2,729,851 | Common Stock | |
| Arvinas Inc | Jakob Loven | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2020 | 12,000 | 12,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges